GH
Guardant Health IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$15.77B
P/E Ratio
—
EPS
$-3.40
Beta
1.49
52W High
$121.01
52W Low
$37.73
50-Day MA
$91.17
200-Day MA
$87.70
Dividend Yield
—
Profit Margin
-40.10%
Forward P/E
—
PEG Ratio
—
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $1.08B |
| Gross Profit (TTM) | $701.01M |
| EBITDA | $-408.16M |
| Operating Margin | -40.20% |
| Return on Equity | -4584.00% |
| Return on Assets | -17.20% |
| Revenue/Share (TTM) | $8.49 |
| Book Value | $-1.38 |
| Price-to-Book | 55.67 |
| Price-to-Sales (TTM) | 14.60 |
| EV/Revenue | 15.16 |
| EV/EBITDA | -5.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 48.30% |
| Shares Outstanding | $132.60M |
| Float | $127.80M |
| % Insiders | 4.05% |
| % Institutions | 105.71% |
Historical Volatility
HV 10-Day
82.91%
HV 20-Day
68.25%
HV 30-Day
60.45%
HV 60-Day
60.01%
HV Rank
69.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($130.52 target)
4
Strong Buy16
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026